Visa filings show Anthropic listing base salaries above $1M for a few technical roles, highlighting how hot the AI hiring wars have become in San Francisco.

Airwallex raised $320M at an $11B valuation as it rolls out AI products that aim to automate finance and launch an agentic consumer wallet.

A San Francisco judge refused to toss a major class action accusing Workday’s AI hiring tools of discriminating by race, age and disability. The decision keeps key claims alive.

The New York Times amended its June 25 complaint, dropping a claim against OpenAI and refocusing its allegations on Microsoft in a major copyright battle.

Apple raised prices on Macs and iPads as AI-driven memory and storage costs surged, pushing some popular entry-level models up by hundreds of dollars. The company says it can no longer absorb soaring component bills.

A Moraga mother is in remission after surgeons used a single‑port robotic system at Alta Bates to remove an aggressive breast tumor, a local milestone for the East Bay.

Alphabet will enter the Dow next Monday, replacing Verizon and boosting tech's footprint in the 30-stock index. The swap highlights quirks in the Dow's price-weighted design.

Salem-based Agility Robotics agreed to merge with Churchill Capital XI in a deal that values the company at about $2.5 billion and aims to scale its RoboFab production. The transaction hinges on shareholder and SEC approvals.

YouTube reached a confidential settlement with a Florida teen who sued over alleged social‑media addiction, exiting a California bellwether trial while Meta, Snap and TikTok face a July jury.

Sunrun, Tesla and startups are pitching a plan to marshal rooftop solar, batteries and smart devices in millions of homes to free power for AI data centers during peak demand. Regulators and local communities are watching closely.

Antares Therapeutics has struck a partnership with Novartis that could be worth about $1.9 billion, bringing fresh funding to its South San Francisco and Boston teams.

Northwestern's Project DRIVE provided software Apple used to let Vision Pro wearers steer powered wheelchairs with their eyes. The feature rolls out initially with limited drive‑system support.

A whistleblower suit unsealed this week alleges decades of kickbacks and false government claims tied to Xolair, naming Genentech, Novartis and other drugmakers.